ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 092,64
-0,60%
Dow Jones
39 872,99
0,17%
DAX
18 655,88
-0,38%
Brent Oil
82,135
-0,38%
Bitcoin
69 973,63
-0,22%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Reunion Neuroscience Inc (REUN)

  7. Reunion Neuroscience Inc (REUN) Actualités

REUN

Reunion Neuroscience (REUN)

Reunion Neuroscience Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:REUN
DateHeureSourceTitreSymboleSociété
03/04/202413h30GlobeNewswire Inc.Reunion Neuroscience Inc. Announces Upcoming Presentations at the Anxiety and Depression Association of America (ADAA) 2024 ConferenceNASDAQ:REUNReunion Neuroscience Inc
27/03/202313h30GlobeNewswire Inc.Reunion Neuroscience Abstract Accepted for Poster Presentation at 2023 ASCP Annual MeetingNASDAQ:REUNReunion Neuroscience Inc
13/03/202323h52GlobeNewswire Inc.Reunion Neuroscience Files Lawsuit Against Mindset PharmaNASDAQ:REUNReunion Neuroscience Inc
07/03/202313h30GlobeNewswire Inc.Reunion Neuroscience to Participate in the Oppenheimer Annual Healthcare ConferenceNASDAQ:REUNReunion Neuroscience Inc
14/02/202313h30GlobeNewswire Inc.Reunion Neuroscience Provides Business Update and Reports Fiscal Third Quarter 2023 Financial ResultsNASDAQ:REUNReunion Neuroscience Inc
02/02/202313h30GlobeNewswire Inc.Reunion Neuroscience Schedules Fiscal Third Quarter 2023 Conference Call for Tuesday, February 14, 2023, at 8:30 A.M. ETNASDAQ:REUNReunion Neuroscience Inc
18/01/202313h30GlobeNewswire Inc.Reunion Neuroscience Appoints Robert Alexander as Chief Medical OfficerNASDAQ:REUNReunion Neuroscience Inc
09/01/202313h30GlobeNewswire Inc.Reunion Neuroscience Inc. Completes Interim Data Analysis for Phase 1 Clinical Trial with Novel Serotonergic Psychedelic RE104NASDAQ:REUNReunion Neuroscience Inc
04/01/202313h30GlobeNewswire Inc.Reunion Neuroscience Inc. Provides 2023 Corporate UpdateNASDAQ:REUNReunion Neuroscience Inc
16/12/202214h35GlobeNewswire Inc.KCSA Mental Health Virtual Investor Conference: Presentations Now Available for Online ViewingNASDAQ:REUNReunion Neuroscience Inc
13/12/202214h35GlobeNewswire Inc.KCSA Mental Health Virtual Investor Conference Agenda Announced for December 15thNASDAQ:REUNReunion Neuroscience Inc
06/12/202214h00GlobeNewswire Inc.Reunion Neuroscience Inc. to Participate in Upcoming Investor Conferences in DecemberNASDAQ:REUNReunion Neuroscience Inc
18/11/202223h05GlobeNewswire Inc.Reunion Neuroscience Puts in Place At-The-Market Equity FacilityNASDAQ:REUNReunion Neuroscience Inc
16/11/202212h20TipRanksAnalysts Offer Insights on Healthcare Companies: BELLUS Health (BLU), Reunion Neuroscience (REUN) and Mainz Biomed B.V. (MYNZ)NASDAQ:REUNReunion Neuroscience Inc
14/11/202213h30GlobeNewswire Inc.Reunion Neuroscience Inc. Provides Business Update and Reports Fiscal Second Quarter 2023 Financial ResultsNASDAQ:REUNReunion Neuroscience Inc
07/11/202213h30GlobeNewswire Inc.Reunion Neuroscience Schedules Fiscal Second Quarter 2023 Conference Call for Monday, November 14, 2022, at 8:30 A.M. ETNASDAQ:REUNReunion Neuroscience Inc
31/10/202212h30GlobeNewswire Inc.Reunion Neuroscience to Present at Upcoming November ConferencesNASDAQ:REUNReunion Neuroscience Inc
24/10/202213h30GlobeNewswire Inc.Reunion Neuroscience Appoints Chief Financial Officer and Vice President, Medical AffairsNASDAQ:REUNReunion Neuroscience Inc
12/10/202213h30GlobeNewswire Inc.Reunion Neuroscience CEO to Participate on Panel at 2022 Horizons Perspectives on Psychedelics ConferenceNASDAQ:REUNReunion Neuroscience Inc
07/10/202223h34TipRanksReunion Neuroscience general counsel Paula Amy Hewitt resignsNASDAQ:REUNReunion Neuroscience Inc
07/10/202223h30GlobeNewswire Inc.Reunion Neuroscience Inc. Announces Executive ChangesNASDAQ:REUNReunion Neuroscience Inc
03/10/202213h30GlobeNewswire Inc.Reunion Neuroscience to Participate in the Cantor Neurology & Psychiatry ConferenceNASDAQ:REUNReunion Neuroscience Inc
29/09/202223h20GlobeNewswire Inc.Reunion Neuroscience Inc. Announces Results of Annual General and Special Shareholder MeetingNASDAQ:REUNReunion Neuroscience Inc
28/09/202213h30GlobeNewswire Inc.Reunion Neuroscience Inc. Appoints Greg Mayes as President and Chief Executive OfficerNASDAQ:REUNReunion Neuroscience Inc
08/09/202214h00GlobeNewswire Inc.Reunion Neuroscience Inc. to Participate in Upcoming Investor ConferencesNASDAQ:REUNReunion Neuroscience Inc
31/08/202213h30GlobeNewswire Inc.Reunion Neuroscience Inc. Announces 2022 Annual General Meeting of ShareholdersNASDAQ:REUNReunion Neuroscience Inc
24/08/202213h55TipRanksReunion Neuroscience (REUN) Gets a Buy from Maxim GroupNASDAQ:REUNReunion Neuroscience Inc
 Showing the most relevant articles for your search:NASDAQ:REUN

Dernières Valeurs Consultées

BMF
DIIF27V27
DIIF27V27 - 01/2027
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés